A majority of atrial fibrillation patients who have not been treated oral anticoagulants (OAC) meet guideline indications for treatment. Untreated patients are at increased risk for adverse outcomes. In this video, AJM editor-in-chief Dr. Joseph S. Alpert discusses this new research in the April 2017 issue of the American Journal of Medicine.
Read the Research:
Absence of Oral Anticoagulation and Subsequent Outcomes Among Outpatients with Atrial Fibrillation
Research articles published in the American Journal of Medicine are free for a limited time. To read all of AJM’s content for free, consider subscribing here.
